Tushar Misra serves as Executive at Mersana Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Tushar Misra has executed 9 insider transactions totaling $27.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 16, 2024 involved selling 3,357 shares valued at $9.1K.
Tushar Misra currently holds 17,966 shares of Mersana Therapeutics, Inc. (MRSN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tushar Misra has been a net seller of MRSN stock. They have purchased $0 and sold $27.3K worth of shares.
Tushar Misra's most recent insider trade was on Jan 16, 2024, when they sold 3,357 shares at $2.71 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Planned |
| Jan 13, 2024 | MRSN | $0 | Option Exercise | 7,083 | $N/A | Planned |
| Aug 17, 2023 | MRSN | $2.3K | Sale | 1,908 | $1.18 | Planned |
| Aug 16, 2023 | MRSN | $0 | Option Exercise | 6,250 | $N/A | Planned |
| Jan 17, 2023 | MRSN | $2.6K | Sale | 458 | $5.74 | Discretionary |
| Jan 14, 2023 | MRSN | $0 | Option Exercise | 1,459 | $N/A | Discretionary |
| Aug 17, 2022 | MRSN | $13.3K | Sale | 1,879 | $7.10 | Discretionary |
| Aug 16, 2022 | MRSN | $0 | Option Exercise | 6,250 | $N/A | Discretionary |